NCT01361113 : Clinical Trial Detail - Cancer Knowledgebase (CKB)

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT01361113
Title	Neoadjuvant Pazopanib in Renal Cell Carcinoma
Recruitment	Completed
Gender	both
Phase	Phase II
Variant Requirements	No
Sponsors	UNC Lineberger Comprehensive Cancer Center
Indications	renal cell carcinoma
Therapies	Pazopanib
Age Groups:	senior \| adult
Covered Countries	USA

Filter rows:

Showing 1 to 2 of 2 entries

Facility	Status	City	State	Zip	Country	Details
MD Anderson Cancer Center		Houston	Texas	77030	United States	Details
North Carolina Cancer Hospital (UNC)		Chapel Hill	North Carolina	27599	United States	Details

Showing 1 to 2 of 2 entries

Filter rows:

*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field

NCT01361113Clinical Trial Detail